Identification Generic Name (10R)-10-formyl-5,8,10-trideazafolic acid DrugBank Accession Number DB04264 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (10R)-10-formyl-5,8,10-trideazafolic acid (DB04264) ×  Close Weight Average: 482.4428  Monoisotopic: 482.1437637  Chemical Formula C 23 H 22 N 4 O 8 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Phosphoribosylglycinamide formyltransferase Not Available Escherichia coli (strain K12) Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Glutamic acid and derivatives Alternative Parents Stilbenes  /  Hippuric acids  /  N-acyl-alpha amino acids  /  Quinazolinamines  /  Aromatic monoterpenoids  /  Bicyclic monoterpenoids  /  Tricarboxylic acids and derivatives  /  Benzoyl derivatives  /  Aminopyrimidines and derivatives  /  Pyrimidones  /  Heteroaromatic compounds  /  Vinylogous amides  /  Amino acids  /  Secondary carboxylic acid amides  /  Carboxylic acids  /  Azacyclic compounds  /  Hydrocarbon derivatives  /  Primary amines  /  Carbonyl compounds  /  Organopnictogen compounds  /  Organic oxides 
 
 
  show 11 more Substituents Amine  /  Amino acid  /  Aminopyrimidine  /  Aromatic heteropolycyclic compound  /  Aromatic monoterpenoid  /  Azacycle  /  Benzamide  /  Benzenoid  /  Benzoic acid or derivatives  /  Benzoyl  /  Bicyclic monoterpenoid  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid  /  Diazanaphthalene  /  Glutamic acid or derivatives  /  Heteroaromatic compound  /  Hippuric acid  /  Hippuric acid or derivatives  /  Hydrocarbon derivative  /  Monocyclic benzene moiety  /  Monoterpenoid  /  N-acyl-alpha amino acid or derivatives  /  N-acyl-alpha-amino acid  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  P-cymene  /  Primary amine  /  Pyrimidine  /  Pyrimidone  /  Quinazolinamine  /  Quinazoline  /  Secondary carboxylic acid amide  /  Stilbene  /  Tricarboxylic acid or derivatives  /  Vinylogous amide 
 
 
  show 31 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key DAOQLLQRJAXMGY-PBHICJAKSA-N InChI InChI=1S/C23H22N4O8/c24-23-26-16-6-1-11(10-15(16)20(31)27-23)9-14(21(32)33)12-2-4-13(5-3-12)19(30)25-17(22(34)35)7-8-18(28)29/h1-6,10,14,17H,7-9H2,(H,25,30)(H,28,29)(H,32,33)(H,34,35)(H3,24,26,27,31)/t14-,17+/m1/s1 IUPAC Name (2S)-2-({4-[(1R)-2-(2-amino-4-oxo-1,4-dihydroquinazolin-6-yl)-1-carboxyethyl]phenyl}formamido)pentanedioic acid SMILES [H]N([H])C1=NC(=O)C2=C(C=CC(C[C@@H](C(O)=O)C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)=C2)N1[H] References General References Not Available External Links PubChem Compound 444729 PubChem Substance 46504612 ChemSpider 392574 ZINC ZINC000003870535 PDBe Ligand NHR PDB Entries 1c3e Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0406 mg/mL ALOGPS logP 0.35 ALOGPS logP 0.77 Chemaxon logS -4.1 ALOGPS pKa (Strongest Acidic) 3.37 Chemaxon pKa (Strongest Basic) 2.91 Chemaxon Physiological Charge -3 Chemaxon Hydrogen Acceptor Count 11 Chemaxon Hydrogen Donor Count 6 Chemaxon Polar Surface Area 208.48 Å 2 Chemaxon Rotatable Bond Count 10 Chemaxon Refractivity 121.68 m 3 ·mol -1 Chemaxon Polarizability 45.97 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption - 0.5669 Blood Brain Barrier - 0.5758 Caco-2 permeable - 0.8076 P-glycoprotein substrate Substrate 0.5 P-glycoprotein inhibitor I Non-inhibitor 0.9644 P-glycoprotein inhibitor II Non-inhibitor 0.987 Renal organic cation transporter Non-inhibitor 0.9148 CYP450 2C9 substrate Non-substrate 0.8098 CYP450 2D6 substrate Non-substrate 0.832 CYP450 3A4 substrate Non-substrate 0.6007 CYP450 1A2 substrate Non-inhibitor 0.9043 CYP450 2C9 inhibitor Non-inhibitor 0.9105 CYP450 2D6 inhibitor Non-inhibitor 0.9438 CYP450 2C19 inhibitor Non-inhibitor 0.9034 CYP450 3A4 inhibitor Non-inhibitor 0.9313 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9515 Ames test Non AMES toxic 0.889 Carcinogenicity Non-carcinogens 0.9675 Biodegradation Not ready biodegradable 0.8759 Rat acute toxicity 2.3336 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9502 hERG inhibition (predictor II) Non-inhibitor 0.8403    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Phosphoribosylglycinamide formyltransferase Kind Protein Organism Escherichia coli (strain K12) Pharmacological action Unknown General Function Phosphoribosylglycinamide formyltransferase activity Specific Function Catalyzes the transfer of a formyl group from 10-formyltetrahydrofolate to 5-phospho-ribosyl-glycinamide (GAR), producing 5-phospho-ribosyl-N-formylglycinamide (FGAR) and tetrahydrofolate. Gene Name purN Uniprot ID P08179 Uniprot Name Phosphoribosylglycinamide formyltransferase Molecular Weight 23238.065 Da References Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [ Article ]  Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 